Market Analysis Reports

Market Analysis - Medicinal Chemistry 2024

Global Market Value of Medicinal Chemistry:

Global Medicinal Chemistry for Drug Discovery Market report is a comprehensive study on how the current state is for market. This report provides a thorough synopsis for the Medicinal Chemistry for Drug Discovery industry. It includes detailed market definition, classifications, applications and for most important the industry chain structure along with market trends and uses SWOT analysis.  The report gives a deep knowledge about Medicinal Chemistry for Drug Discovery Market and shows the important product developments and tracks recent acquisitions, merges and research in the industry. This report provides the forecast for the years 2019 to 2026.

The global Medicinal Chemistry is segmented on the basis of type, drug type and therapeutic area. Based on type, the market is segmented as biology services, medicinal chemistry and drug metabolism and pharmacokinetics. On the basis of the drug type the segment is classified as biologics and small molecules. Similarly, on the basis of therapeutic area the segment is divided into cardiovascular diseases, oncology, neurology, diabetes, respiratory diseases and others.

Chemistry volumes continue to rise in the U.S. and chemical market expected to contract this year—As a result, chemical industry capital spending in the U.S. surged 12.1% in 2014 and gained 21.0% in 2015, reaching $43.58 billion and accounting for more than one-half of total construction spending by the manufacturing sector. The association representing US-based chemical producers said that US chemical production (excluding pharmaceuticals) is expected to realize the overall growth of 1.6% in 2016, followed by 4.1% growth next year, and 5.0% in 2018. Average annual gains of over 8% per year in U.S.

Chemical industry capital spending are expected through 2018 with only a minor slowdown in subsequent growth expected. By 2021, ACC expects capital spending to reach $70 billion, contributing to four consecutive years of job growth in the industry. American chemistry revenues will exceed $1.0 trillion by 2020. 

Chemistry Council stated that more than 275 new chemical production projects had been announced since 2010 with a total value of more than $170 billion, with a full 49% already complete or under construction; 61% of these are the foreign direct investment. By 2021, U.S. capital spending by the chemical industry will reach $65 billion—more than triple the level of spending at the start of this prolonged cycle in 2010. The trade surplus in chemicals (excluding pharmaceuticals) will grow to $36 billion this year as exports rise by 2% to $132 billion and imports hold steady at $96 billion. Two-way trade between the U.S. and its foreign partners will reach $227 billion this year and will grow steadily over the coming years.

Medicinal Chemistry Market:

Medicinal Chemistry Systems Market Report provides a relevant source of perceptive data for investors. Medicinal Chemistry Market Report also examines global Medicinal Chemistry Systems Industry growth analysis, the past and innovative cost, demand and supply information, and revenue.

Chemical companies from the United States are among the industry’s leading global players. With revenue of 48.2 billion U.S. dollars in 2016, Dow Chemical is the largest U.S. chemical company, and the world’s third largest behind German chemical companies BASF and Bayer. Other U.S. top companies are Lyondell Basell, DuPont and Praxair. In 2016, several of the leading global chemical companies announced mergers, effectively changing the dynamics of the global chemical industry.

The U.S. is the world’s largest exporter of chemical goods. In 2016, chemical exports were worth some 185 billion U.S. dollars. Most of it was generated through exports to the Asia-Pacific region. The leading countries of destination for chemical exports from the U.S. were Canada, Mexico, and China. However, the U.S. also has a large demand for chemical imports. In 2016, these imports were worth around 206 billion U.S. dollars. 

The U.S. chemical industry spends relevant amounts for research and development. In 2016, almost 91 billion U.S. dollars were spent for R&D purposes in the chemical industry. That means that R&D funds have almost doubled over the last decade. Accordingly, the United States is the global leader in developing new chemical and pharmaceutical entities.

Target Audience:

• Professors in Pharmaceutical sciences and Chemistry
• Associate and Assistant Professors in Pharmaceutical sciences and Chemistry
• Post-doctoral and Researchers in Pharmaceutical sciences and Chemistry
• Heads of Pharmaceutical sciences and Chemistry Departments
• Post Graduates and Graduates in Pharmaceutical sciences and Chemistry
• Laboratory Chemists
• Chemical Scientists working on Medicinal Chemistry
• Experts in the development of Medicinal Chemistry

Related Companies/Industries:

Abbott Laboratories	Amedis Pharmaceuticals	Barnstead International	Becton, Dickinson and Company
Chemistry-software.com	DMV International Pharma	Exchem Mining & Construction	Johnson Matthey
Key Organics Limited	May bridge Chemicals	National Physical Laboratory (NPL)	Oxford Analytical Ltd
Senn Chemicals	Target Molecules	United Kingdom Atomic Energy Authority (UKAEA)	Vertex Pharmaceuticals Inc.
Zinsser Analytic	WRc-NSF Ltd	Strem Chemicals	RSSL Pharma
Pharmacia Corporation	Personal Chemistry	Novabiochem	MDS Pharma Services
Forensic Science Service (FSS)	Current Science Group (CSG)	Pfizer	Zoetis

 

Chemistry Conferences welcome chemical professionals, researchers, professors, scientific communities, delegates, students, business professionals and executives from all over the world to attend the “24^th World Congress on Medicinal Chemistry and Drug Design” which is to be held during June 13-14, 2024 at Rome, Italy. Which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Medicinal Chemistry 2024 which is the primordial chemistry conferences serves as a global platform to discuss and learn about Medicinal Chemistry, Pharmaceutical Sciences, Drug Design and Drug Development, CADD (Computer Aided Drug Design), Bioorganic and Medicinal Chemistry, Pharmacology and toxicology, Anticancer agents in Medicinal Chemistry, Analytical Chemistry, Pharmaceutical Industry, Organic Chemistry, Clinical Pharmacology,  Evolution of Organic and Medicinal Chemistry in Pharma,  Organic and Medicinal Chemistry Technologies for Drug Discovery, QSAR (Quantitative Structure-Activity Relationship) Fragment-Based Drug Design, Applications of Organic and Medicinal Chemistry in Drug Discovery, Market Dynamics, Conclusions and Future Trends, Medicinal Plants

In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of chemistry, pharmacy, Medicinal Chemistry and Drug Design by providing a platform for critical analysis of new designing, and to share latest cutting-edge research findings and results about all aspects of Medicinal Chemistry. The current meeting of chemistry conferences will be a multinational gathering and present major areas such as Medicinal Chemistry, Pharmaceutical Sciences, Drug Design and Drug Development, Organic Chemistry and overall applications.

Target Audience:

• Professors in Pharmaceutical sciences and Chemistry
• Associate and Assistant Professors in Pharmaceutical sciences and Chemistry
• Post-doctoral and Researchers in Pharmaceutical sciences and Chemistry
• Heads of Pharmaceutical sciences and Chemistry Departments
• Post Graduates and Graduates in Pharmaceutical sciences and Chemistry
• Laboratory Chemists
• Chemical Scientists working on Medicinal Chemistry
• Experts in the development of Medicinal Chemistry
• The field of Medicinal Chemistry and Chemistry involves wide range of sectors of markets growing respectively.

Conference Series organizes 1000+ Global events  every year across  the globe with support from 1000+ more scientific societies and Publishes 700 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Young Scientist Benefits

• Our conferences provide best Platform for your research through oral presentations.
• Share the ideas with both eminent researchers and mentors.
• Young Scientist Award reorganization certificate and memento to the winners
• Young Scientists will get appropriate and timely information by this Forum.
• Platform for collaboration among young researchers for better development
• Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.